Xencor Inc (XNCR)
19.23
+0.21
(+1.10%)
USD |
NASDAQ |
Apr 25, 16:00
19.24
+0.01
(+0.05%)
After-Hours: 20:00
Xencor Cash and Short Term Investments (Quarterly): 593.72M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 593.72M |
| September 30, 2023 | 494.53M |
| June 30, 2023 | 551.37M |
| March 31, 2023 | 588.02M |
| December 31, 2022 | 623.06M |
| September 30, 2022 | 600.24M |
| June 30, 2022 | 511.92M |
| March 31, 2022 | 389.76M |
| December 31, 2021 | 334.11M |
| September 30, 2021 | 288.20M |
| June 30, 2021 | 450.05M |
| March 31, 2021 | 551.98M |
| December 31, 2020 | 603.00M |
| September 30, 2020 | 551.16M |
| June 30, 2020 | 586.26M |
| March 31, 2020 | 573.90M |
| December 31, 2019 | 529.78M |
| September 30, 2019 | 546.48M |
| June 30, 2019 | 505.17M |
| March 31, 2019 | 340.36M |
| December 31, 2018 | 294.36M |
| September 30, 2018 | 271.60M |
| Date | Value |
|---|---|
| June 30, 2018 | 255.41M |
| March 31, 2018 | 462.41M |
| December 31, 2017 | 224.13M |
| September 30, 2017 | 209.95M |
| June 30, 2017 | 188.49M |
| March 31, 2017 | 154.79M |
| December 31, 2016 | 130.14M |
| September 30, 2016 | 104.30M |
| June 30, 2016 | 91.10M |
| March 31, 2016 | 92.36M |
| December 31, 2015 | 96.43M |
| September 30, 2015 | 127.94M |
| June 30, 2015 | 67.88M |
| March 31, 2015 | 144.24M |
| December 31, 2014 | 54.65M |
| September 30, 2014 | 60.92M |
| June 30, 2014 | 66.22M |
| March 31, 2014 | 72.54M |
| December 31, 2013 | 77.98M |
| September 30, 2013 | 9.621M |
| June 30, 2013 | 11.75M |
| December 31, 2012 | 2.312M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
288.20M
Minimum
Sep 2021
623.06M
Maximum
Dec 2022
519.62M
Average
551.16M
Median
Sep 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.331B |
| Karyopharm Therapeutics Inc | 191.44M |
| NovaBay Pharmaceuticals Inc | 3.13M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |